Pancreatic cancer has one of the lowest survival rates of any cancer. But for the first time in a long time — there is real hope. A new drug called Daraxonrasib just became the first treatment in a clinical trial to substantially extend the lifespans of patients fighting this disease — by targeting the mutated KRAS protein that drives rapid tumor growth, a target scientists once considered virtually "undruggable." But knowledge is still your first line of defense. Here's what to watch for: → Sudden, unexplained weight loss → Painless yellowing of the skin or eyes → Persistent belly or lower back pain → A new diabetes diagnosis in an older adult — it can actually be an early warning sign of a hidden tumor The hardest part? Most people feel no symptoms at all until the cancer is already advanced. For our community — which already faces barriers to early detection and quality care — knowing this isn't optional. It's essential. 🔗 Full breakdown at the link in bio. #Blavity #BlavityHe...